Biotech/Medical Tech Stock News from Investorideas.com: July 2021

Friday, July 30, 2021

New #Stocks to Watch at Investor Ideas in Cleantech (Nasdaq: $ENVX), Mining (Nasdaq: $OMEX), Tech (Nasdaq: $OSS, Nasdaq: $OBLG) and Biotech (Nasdaq: $OCGN)

New #Stocks to Watch at Investor Ideas in Cleantech (Nasdaq: $ENVX), Mining (Nasdaq: $OMEX), Tech (Nasdaq: $OSS, Nasdaq: $OBLG) and Biotech (Nasdaq: $OCGN)

Point Roberts WA, Delta BC, July 30, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and expert investing resource, announces its weekly roundup of stocks to watch in cleantech, mining, tech and biotech. Today’s stocks have been added to our lists of free stock directories in each sector.

The newest cleantech stock is involved in batteries, including those for electric vehicles, while the latest mining companies are involved in mining in Canada and ocean exploration, respectively.

The newest tech companies are involved in Artificial Intelligence (AI) and cloud services.

The latest biotech companies are a biopharma company involved in COVID19 vaccines and an acquisition company for medical technologies.

New Stocks added to Cleantech Stocks Directory:

Enovix Corporation (NASDAQ: ENVX) is the leader in advanced silicon-anode lithium-ion battery development and production. The company's proprietary 3D cell architecture increases energy density and maintains high cycle life. Enovix is building an advanced silicon-anode lithium-ion battery production facility in the U.S. for volume production. The company's initial goal is to provide designers of category-leading mobile devices with a high-energy battery so they can create more innovative and effective portable products. Enovix is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable widespread utilization of renewable energy.

New stocks added to Mining Stocks Directory:

Cirrus Gold Corp. (CSE:CI) is engaged in the business of mineral exploration and the acquisition of mineral property assets in Canada. Its objective is to locate and develop economic precious and base metal properties of merit and to conduct its exploration program on the Chuchi South Property. The Chuchi South Property consists of thirteen mineral claims covering an area of 3,118.7 hectares located approximately 185 km northwest of the City of Prince George, within the Omineca Mining Division, British Columbia.

Odyssey Marine Exploration (NasdaqGS:OMEX) is engaged in ocean exploration using innovative methods and state-of-the-art technology to provide access to critical resources worldwide. Our core focus is the discovery, validation and development of subsea mineral resources. Odyssey also provides marine services for private clients and governments.

New Stocks added to Tech Stocks Directory:

One Stop Systems (NasdaqGS:OSS) designs and manufactures innovative AI Transportable edge computing modules and systems, including ruggedized servers, compute accelerators, expansion systems, flash storage arrays and Ion Accelerator™ SAN, NAS and data recording software for AI workflows. These products are used for AI data set capture, training, and large-scale inference in the defense, oil and gas, mining, autonomous vehicles and rugged entertainment applications. OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe storage to build award-winning systems, including many industry firsts, for industrial OEMs and government customers. The company enables AI on the Fly® by bringing AI datacenter performance to ‘the edge’, especially on mobile platforms, and by addressing the entire AI workflow, from high-speed data acquisition to deep learning, training and inference. OSS products are available directly or through global distributors.

Oblong Inc. (NasdaqGS:OBLG) provides innovative and patented technologies that change the way people work, create, and communicate. Oblong’s flagship product Mezzanine™ is a remote meeting technology platform that offers simultaneous content sharing to achieve situational awareness for both in-room and remote collaborators. Oblong supplies Mezzanine systems to Fortune 500 enterprise customers and is a Cisco Solutions Plus integration partner.

New Stocks added to Biotech Stocks Directory:

Ocugen, Inc. (NasdaqGS:OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug — “one to many,” and our novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. We are co-developing Bharat Biotech’s COVAXIN™ vaccine candidate for COVID-19 in the U.S. and Canadian markets.

Odyssey Group International (OTC:ODYY) is a technology and asset acquisition company with a focus in the area of life saving medical solutions. Odyssey's corporate mission is to create, acquire and accumulate distinct assets, intellectual properties, and exceptional technologies that provide meaningful medical solutions. The Company is focused on building and acquiring assets in areas that have an identified technological advantage, provide superior clinical utility, have a substantial market opportunity and provide solid returns to its valued shareholders and partners.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast , Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye Podcast.

Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Wednesday, July 28, 2021

Breaking #AI #Health #Stock News: GBT (OTC: $GTCH) Considers Using an AI Accelerator for its xCalibre (internal project name) Pattern Recognition #Technology; #artificialintelligence

Breaking #AI #Health #Stock News: GBT (OTC: $GTCH) Considers Using an AI Accelerator for its xCalibre (internal project name) Pattern Recognition #Technology; #artificialintelligence

Aiming to Significantly Boost its Data Processing Performance

SAN DIEGO, CA, July 28, 2021 - (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT” or the “Company”), considers AI accelerating technology for its xCalibre image analysis to significantly enhance its processing speed. xCalibre imaging technology, processes high resolution images and videos; and can also detect a wide variety of objects. The system includes GBT’s proprietary AI technology along with its computational geometry algorithms and can be used for wide variety of domains.

Read this news, featuring GTCH In full at https://www.investorideas.com/CO/GOPH/news/2021/07281AI-Accelerator-xCalibre.asp

For example, live or post processing of health imaging like CT Sans, Ultrasound, MRI and X-RAY, and detecting anomalies. Another possible application is real-time security surveillance which the system analyzes real time surveillance camera data while identifying persons or objects of interest. Such system requires vast amount of computing power along with advanced AI big data algorithms. GBT is now evaluating to accompany xCalibre with a complementary AI accelerator hardware. An AI accelerating system is a high-performance hardware that is designed to work in conjunction with an AI algorithm, enabling ultra-fast data processing.

Typically, such a system includes parallel computation machine that is exclusively designed to increase neural network and other AI algorithms processing efficiency. A high level of processing optimization can be achieved by using a combination of AI programming with specifically designed hardware for it. GBT evaluates adapting its AI algorithms with accelerating hardware targeting to significantly boost its xCalibre imaging performance. This combined system is planned to be self-optimized. A neural network program that is running with a supporting, parallel computing hardware, that will be capable of processing massive amounts of data through iterative optimization. GBT will evaluate the use of specific hardware including Graphics Processing Units (GPUs), Multicore Processors and Spatial Accelerators. xCalibre’s cognitive capabilities enable it to accumulate knowledge exactly as a human would do, which requires vast amount of computing power. GBT believes that a hardware AI accelerator that will work in conjunction with xCalibre’s imaging, can enable much faster data processing, enabling HD/UHD real time image and video processing.

"Our xCalibre system is a huge computing power consumer and we are using our AI based big data algorithms in it to enable fast processing. Additionally, we are using advanced computational geometry algorithms to scan, pixelate and analyze images. As part of our ongoing enhancements efforts and to ensure rapid, real time processing, we decided to evaluate an additional AI hardware accelerating system. We aim to adapt our AI algorithms to work with specific hardware that is especially designed to accelerate neural network and other AI related algorithms. The combination of an accelerating hardware with our AI programs is aimed to produce an ultra-fast performance. We plan to implement the AI accelerator with our xCalibre imaging due to its computer vision characteristics. xCalibre is targeted for a real time processing of HD/UHD videos and images and had cognitive capabilities. As more images and videos are analyzed the system records the information for future use. One of the interesting possible application is a real time surveillance video analysis where it can detect persons or objects of interest. Another possible application is the analysis of health-related images like MRI, X-Ray, CT and Ultrasound. These types of applications require a massive computing power and data handling. We are making constant efforts to improve and enhance our technology and believe that a custom AI accelerator will majorly boost xCalibre’s performance, making it an efficient candidate for autonomous vehicles computer vision, health and security applications,” said Danny Rittman the Company’s CTO.

There is no guarantee that the Company will be successful in researching, developing or implementing this system. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT’s mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT’s goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT’s vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company’s ability to raise capital on acceptable terms, if at all, the Company’s successful development of its products and the integration into its existing products and the commercial acceptance of the Company’s products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

Get News Alerts on GBT Technologies Inc GTCH

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Friday, July 16, 2021

New #Stocks to Watch at Investor Ideas in Tech (NYSE: $ZETA) (Nasdaq: $MQ), Biotech (Nasdaq: $JANX) (Nasdaq: $LFST) and Plant-Based (CSE: $YUMY.C)

New #Stocks to Watch at Investor Ideas in Tech (NYSE: $ZETA) (Nasdaq: $MQ), Biotech (Nasdaq: $JANX) (Nasdaq: $LFST) and Plant-Based (CSE: $YUMY.C)

Point Roberts WA, Delta BC, July 16, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Tech, Biotech and Plant-Based. Today’s stocks have been added to our lists of free stock directories in each sector.

Read this in full at https://www.investorideas.com/news/2021/main/07161Stocks.asp

The newest tech companies are involved in internet portals/websites, Artificial Intelligence (AI), Cloud computing, Fintech, Software and E-Commerce.

The latest biotech companies are involved in biopharmaceuticals, mental health and disease prevention.

The newest plant-based company is an affordable health-conscious low-sugar plant-based confectionary company.

New Stocks added to Tech Stocks Directory:

nDivision Inc. (OTC:NDVN) provides Autonomic Managed Services and End User Help Desk services to private and public entities, ranging from small businesses to Fortune 500 global enterprises. The Company leverages proprietary intelligent automation technologies to replace expensive human resources. Automation resolves IT issues faster and more accurately than human engineers, driving previously unattainable service levels. The Company manages public clouds, private clouds, and networks across 34 countries and 6 continents, 24-hours a day, 365 days per year. On average, nDivision resolves 83% of all infrastructure incidents using Intelligent Automation with no human involvement, resulting in a 40% to 60% reduction in the cost of IT operations. Customers rate 96% of incidents that nDivision's technical support staff resolve as either "satisfied" or "very satisfied".One of the top ten global solution providers ($90bn+ revenues) resells nDivision's services across the U.S., and a second ($140bn+ revenues) is assisting nDivision with its channel sales strategy through its sponsorship and introductions to a number of large scale partners

Zeta Global Holdings Corp. (NYSE:ZETA) is a leading data-driven, cloud-based marketing technology company that empowers enterprises to acquire, grow and retain customers. The Company’s Zeta Marketing Platform (the "ZMP") is the largest omnichannel marketing platform with identity data at its core. The ZMP analyzes billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated artificial intelligence to personalize experiences at scale. Founded in 2007 by David A. Steinberg and John Sculley, the Company is headquartered in New York City

Marqeta, Inc. (NasdaqGS:MQ) modern card issuing platform empowers its customers to create customized and innovative payment cards. Marqeta’s modern architecture gives its customers the ability to build more configurable and flexible payment experiences, accelerating time-to-market and democratizing access to card issuing technology. Marqeta’s open APIs provide instant access to highly scalable, cloud-based payment infrastructure that enables customers to launch and manage their own card programs, issue cards and authorize and settle payment transactions. Marqeta is headquartered in Oakland, California and is certified to operate in 36 countries globally.

dLocal Ltd (NasdaqGS:DLO) powers local payments in emerging markets connecting global enterprise merchants with billions of emerging market consumers in 29 countries across APAC, the Middle East, Latin America, and Africa. Through the “One dLocal” concept (one direct API, one platform, and one contract), global companies can accept payments, send payouts and settle funds globally without the need to manage separate pay-in and payout processors, set up numerous local entities, and integrate multiple acquirers and payment methods in each market.

monday.com Ltd. (NasdaqGS:MNDY) The monday.com Work OS is an open platform that democratizes the power of software so organizations can easily build software applications and work management tools to fit their every need. The platform intuitively connects people to processes and systems, empowering teams to excel in every aspect of their work. monday.com has teams in Tel Aviv, New York, San Francisco, Miami, Chicago, London, Kiev and Sydney. The platform is fully customizable to suit any business vertical and is currently used by over 125,000 customers across over 200 industries in more than 190 countries.

1stdibs.com, Inc. (NasdsaqGS:DIBS) is a leading online marketplace for connecting design lovers with highly coveted sellers and makers of vintage, antique, and contemporary furniture, home décor, art, jewelry, watches and fashion.

Kanzhun Ltd (NasdaqGS:BZ) is now the largest online recruitment platform in China in terms of average MAU. We are a pioneer in introducing a disruptive model which is transforming China’s online recruitment industry – the Direct Recruitment Model. Our mobile-native product promotes instant direct chats between Bosses and job seekers, delivers accurate recommendation results, and is powered by proprietary AI algorithms and big data insights. We connect job seekers and enterprise users in an efficient and seamless manner mainly through our highly interactive BOSS Zhipin mobile app, which together with our other mobile apps and mini programs create a vibrant platform covering all kinds of jobseekers (white and gold collar, blue collar and colleague students) and enterprise users (incl. Bosses and recruiting professionals) from various industries within different size of enterprises.

NameSilo Technologies (CSE:URL.CN) invests its capital in companies and opportunities, which management believes are undervalued and have potential for significant appreciation. The company makes investments in both public and private markets, and focuses on opportunities in a wide variety of industries, excluding the resource and resource service sectors. Namesilo does not invest on behalf of any third party, and it does not offer investment advice. Namesilo LLC is a low-cost provider of domain name registration and management services. As an accredited ICANN (Internet Corp. for Assigned Names and Numbers) registrar, Namesilo is one of the fastest-growing domain registrars in the world with approximately 3.4 million active domains under management, and over 170,000 active customers from approximately 160 countries.

Nanalysis Corp. (TSX:NSCI.V) is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D). Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology. Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.

New Stocks added to Biotech Stocks Directory:

Janux Therapeutics, Inc. (NasdaqGS:JANX) is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.

LifeStance Health Group, Inc. (NasdaqGS:LFST) is one of the nation's largest providers of virtual and in-person outpatient behavioral health care for children, adolescents and adults experiencing a variety of mental health conditions. The company delivers personalized, data-driven and comprehensive care to help patients stay healthy and employs over 3,300 psychiatrists, advanced practice nurses, psychologists and therapists. LifeStance Health currently operates across 27 states and over 370 centers.

Newtopia (TSX:NEWU.V) is a tech-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. As a provider of whole person care, we prevent, reverse, and slow the progression of chronic disease while enriching mental health, resilience and overall human performance. Newtopia's programs leverage genetic, social, and behavioral insights to create individualized prevention programs with a focus on type 2 diabetes, heart disease, stroke and weight. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed on the Toronto Stock Exchange (TSXV: NEWU).

New Stocks added to Plant-Based Stocks Directory:

Yumy Bear Goods Inc. (CSE: YUMY) is an affordable health-conscious low-sugar plant-based confectionary company based in Vancouver, British Columbia and it has developed a portfolio of healthier gelatine-free candies made from Non-GMO ingredients with proprietary recipes. All of its products are free of gelatin, soy, gluten, nuts, dairy, eggs, sugar alcohols, artificial sweeteners and genetically modified organisms.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

About Investorideas.com - News that Inspires Big Investing Ideas

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

Download our Mobile App for iPhone and Android

Join our Investor Club https://www.investorideas.com/membership/

Contact Investorideas.com

800 665 0411

Thursday, July 15, 2021

Breaking #AI #Health #Stock News: GBT (OTC: $GTCH) Launches Large Scale Testing For Its qTerm GEN II Prototype; #ArtificialIntelligence

Breaking #AI #Health #Stock News: GBT (OTC: $GTCH) Launches Large Scale Testing For Its qTerm GEN II Prototype; #ArtificialIntelligence

This Larger Scale Testing Aims To Collect Expanded Data From General Population And To Be Used For Potential #FDA Certification Process

SAN DIEGO, CA - July 15, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is launching a larger scale testing for its qTerm GEN II prototype device. GEN II release is a second release that includes series of enhancements for higher accuracy, consistency and compatibility with a broader spectrum of user’s usage and behavior.

Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/07151qTerm-GEN-II-Prototype.asp

GBT's qTerm, a human vitals intelligence device is aimed to measure human vitals with a touch of a finger. Initial results of qTerm’s GEN II prototype are successful and the company is launching phase II testing for a larger group of users. In this testing we will test the device on a vast age group of volunteers. Additionally, we plan to perform testing in different geographical locations and their surrounding environments. The data will be recorded and analyzed to conclude the device’s; software, analytics and mobile application. The qTerm device measures body temperature, blood oxygen and heart rate – vitals and the next release plans possibly to include blood pressure.

The device includes sensors for oxygen (SPO2), heart rate and IR (Infra-Red) type for temperature. A coprocessor chip provides an advanced adjusting algorithm to support broader user’s measuring habits, while compensating for different inputs. The device is accompanied by a smartphone app and synchronized web application to keep a history and provide analytics. This larger scale testing phase data is targeted to also to be used for the FDA certification process, certification which there is no guaranty the Company will be able to obtain.

"We are expanding our qTerm’s testing scale as phase I testing produced very successful results. qTerm GEN II has proven to offer better compatibility for the general population with accurate result’s and overall reliability. Phase II testing will include a larger number of users within wider age group, diverse health conditions, lifestyle and occupation. We are interested to learn more about how, where and when people will be using the device, throughout their daily lives. We will evaluate qTerm prototype for user’s measurement habits and record the data for further analysis. GEN II version improvements significantly increase the device’s overall performance, accuracy and consistency. We target the larger scale testing to be used as part of the potential FDA certification process. qTerm’s device is planned for personal and telemedicine usages. Based on the larger scale data we expect to fine tune the device’s software and mobile application. The device is planned to include an Artificial Intelligence technology that will be offering personal calibration, real-time health statistics and monitoring. One of the major aspects for our larger testing group is to get more data about the devices ease of use and user friendliness aspects. The larger scale testing is planned to take about 30 days, which shortly after, we plan to start creating a commercial version to be handed in. We have a wide variety of potential business partners and customers for qTerm and believe that it can be an efficient health monitoring device. As part of our thorough quality assurance processes we are on a constant mission to ensure the device’s highest performance, bringing it to the highest standards and industry’s regulations," said Danny Rittman the Company’s CTO.

There is no guarantee that the Company will be successful in researching, developing or implementing this testing, or in obtaining FDA certification. In order to successfully implement this concept, the Company will need to raise adequate capital to support its research and, if successfully researched, developed and granted regulatory approval, the Company would need to enter into a strategic relationship with a third party that has experience in manufacturing, selling and distributing this product. There is no guarantee that the Company will be successful in any or all of these critical steps.

About Us

Forward-Looking Statements

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

Get News Alerts on GBT Technologies Inc GTCH

Get more tech stocks investor ideas- news, articles, podcasts and stock directories

Disclaimer

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investorideas.com newswire, breaking biotechnology and pharma news

Friday, July 30, 2021

New #Stocks to Watch at Investor Ideas in Cleantech (Nasdaq: $ENVX), Mining (Nasdaq: $OMEX), Tech (Nasdaq: $OSS, Nasdaq: $OBLG) and Biotech (Nasdaq: $OCGN)

Wednesday, July 28, 2021

Breaking #AI #Health #Stock News: GBT (OTC: $GTCH) Considers Using an AI Accelerator for its xCalibre (internal project name) Pattern Recognition #Technology; #artificialintelligence

Friday, July 16, 2021

New #Stocks to Watch at Investor Ideas in Tech (NYSE: $ZETA) (Nasdaq: $MQ), Biotech (Nasdaq: $JANX) (Nasdaq: $LFST) and Plant-Based (CSE: $YUMY.C)

Thursday, July 15, 2021

Breaking #AI #Health #Stock News: GBT (OTC: $GTCH) Launches Large Scale Testing For Its qTerm GEN II Prototype; #ArtificialIntelligence